Work Group Concludes EMFs Are Possible Human Carcinogen

[1]  D. Newgreen,et al.  The migration of neural crest cells. , 1986, International review of cytology.

[2]  E. Levin.  Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Hoal,et al.  The regulation of tissue plasminogen activator activity by human fibroblasts , 1983, Cell.

[4]  D. Lawrence,et al.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. Wilson,et al.  The secretion of plasminogen activators by human myeloid leukemic cells in vitro. , 1983, Blood.

[6]  P. Seeburg,et al.  Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli , 1983, Nature.

[7]  E. Hoal,et al.  Variable effects of retinoids on two pigmenting human melanoma cell lines. , 1982, Cancer research.

[8]  J. Cairncross,et al.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets , 1982, The Journal of experimental medicine.

[9]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[10]  S. Kohga,et al.  Plasminogen Activators In Human Malignant Melanoma , 1984, Thrombosis and Haemostasis.

[11]  B. Glimelius,et al.  Analysis of developmentally homogeneous neural crest cell populations in vitro. III. Role of culture environment in cluster formation and differentiation. , 1981, Cell differentiation.

[12]  L. Old,et al.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Roblin,et al.  Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells. , 1980, Cancer research.

[14]  R. Roblin,et al.  Immunological quantitation and immunoadsorption of urokinase-like plasminogen activators secreted by human cells. , 1980, The Journal of biological chemistry.

[15]  E. Hoal,et al.  Molecular species of plasminogen activators secreted by normal and neoplastic human cells. , 1980, Cancer research.

[16]  E. Wilson,et al.  Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro , 1978, International journal of cancer.

[17]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[18]  L. Fink,et al.  In vitro plasminogen activator activity in human brain tumors. , 1978, Cancer research.

[19]  P. Black,et al.  Cell density‐dependent secretion of plasminogen activator by 3T3 cells , 1977, Journal of cellular physiology.

[20]  T. Chen,et al.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. , 1977, Experimental cell research.

[21]  B. Giovanella,et al.  Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes. , 1976, Journal of the National Cancer Institute.

[22]  P. McCulloch,et al.  Characterization of human maligant melanoma cell lines. I. Morphology and growth characteristics in culture. , 1975, Journal of the National Cancer Institute.

[23]  H. Kitamura,et al.  Studies of tumor cell lines derived from patients with malignant melanoma. , 1975, Oncology.

[24]  I. Macpherson.  Soft Agar Techniques , 1973 .

[25]  K. Halprin,et al.  A sensitive fluorometric assay method for mammalian tyrosinase. , 1967, Biochemical and biophysical research communications.

[26]  D. Newgreen,et al.  The migration of neural crest cells. , 1986, International review of cytology.

[27]  E. Levin.  Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Hoal,et al.  The regulation of tissue plasminogen activator activity by human fibroblasts , 1983, Cell.

[29]  D. Lawrence,et al.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Wilson,et al.  The secretion of plasminogen activators by human myeloid leukemic cells in vitro. , 1983, Blood.

[31]  P. Seeburg,et al.  Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli , 1983, Nature.

[32]  E. Hoal,et al.  Variable effects of retinoids on two pigmenting human melanoma cell lines. , 1982, Cancer research.

[33]  J. Cairncross,et al.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets , 1982, The Journal of experimental medicine.

[34]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[35]  S. Kohga,et al.  Plasminogen Activators In Human Malignant Melanoma , 1984, Thrombosis and Haemostasis.

[36]  B. Glimelius,et al.  Analysis of developmentally homogeneous neural crest cell populations in vitro. III. Role of culture environment in cluster formation and differentiation. , 1981, Cell differentiation.

[37]  L. Old,et al.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Roblin,et al.  Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells. , 1980, Cancer research.

[39]  R. Roblin,et al.  Immunological quantitation and immunoadsorption of urokinase-like plasminogen activators secreted by human cells. , 1980, The Journal of biological chemistry.

[40]  E. Hoal,et al.  Molecular species of plasminogen activators secreted by normal and neoplastic human cells. , 1980, Cancer research.

[41]  E. Wilson,et al.  Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro , 1978, International journal of cancer.

[42]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[43]  L. Fink,et al.  In vitro plasminogen activator activity in human brain tumors. , 1978, Cancer research.

[44]  P. Black,et al.  Cell density‐dependent secretion of plasminogen activator by 3T3 cells , 1977, Journal of cellular physiology.

[45]  T. Chen,et al.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. , 1977, Experimental cell research.

[46]  B. Giovanella,et al.  Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes. , 1976, Journal of the National Cancer Institute.

[47]  P. McCulloch,et al.  Characterization of human maligant melanoma cell lines. I. Morphology and growth characteristics in culture. , 1975, Journal of the National Cancer Institute.

[48]  H. Kitamura,et al.  Studies of tumor cell lines derived from patients with malignant melanoma. , 1975, Oncology.

[49]  I. Macpherson.  Soft Agar Techniques , 1973 .

[50]  K. Halprin,et al.  A sensitive fluorometric assay method for mammalian tyrosinase. , 1967, Biochemical and biophysical research communications.